[Cytostatic therapy of hemoblastoses and malignant tumors with a methylhydrazine derivative].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001856:Bone Marrow Examination; D001943:Breast Neoplasms / Q000188:drug therapy*; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy*; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D007938:Leukemia / Q000188:drug therapy*; D008199:Lymphadenitis / Q000188:drug therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D008875:Middle Aged; D013584:Sarcoma, Synovial / Q000188:drug therapy*
D006834:Hydrazines
Zytostatische Therapie von Hämoblastosen und Malignomen mit einem Methylhydrazinderivat.